Nellix takes $6M to treat aneurysms before they happen
Nellix Endovascular, a Palo Alto, Calif.-based maker of devices used to repair damaged blood vessels that could lead to aneurysms, has raised $6 million in debt, rights and securities, according to a filing with the SEC. Its backers include Essex Woodlands Health Ventures and Incept.
Next Story: Fusion-io gets its power-saving memory cards into MySpace data centers
Previous Story: Ubicom snaps up $4.4M for home networking processors
About the Author, Camille Ricketts
Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.
VB Writers
Ben PopperEast Coast Editor
Dean TakahashiLead Writer, GamesBeat
Devindra HardawarNational Editor, MobileBeat Lead
Dylan TweneyExecutive Editor
ShoeEditor-in-Chief, GamesBeat
Heather KellySenior Editor
Jennifer Van GroveWriter
Jolie O'DellWriter
Matt MarshallFounder & Editor-in-Chief
Meghan KellyWriter
Sarah MitroffEditorial Assistant
Sean LudwigWriter
Sebastian HaleyReviews Editor, GamesBeat
Tom CheredarWriter
Ciara ByrneContributor
Julia PlevinContributor
Lindsey ComptonContributor
